药物对比
Alogliptin vs Troglitazone
Alogliptin vs Troglitazone治疗2型糖尿病：Alogliptin是更安全的DPP-4抑制剂，而Troglitazone因肝毒性已退市。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes seeking alternatives to older diabetes drugs may compare Alogliptin to Troglitazone.
结论
Alogliptin is a safer and more effective choice than the discontinued Troglitazone for managing type 2 diabetes.
全部药物对比